Orasure Technologies Inc Sample Contracts

AutoNDA by SimpleDocs
ORASURE TECHNOLOGIES, INC. 8,000,000 Shares of Common Stock Underwriting Agreement
Underwriting Agreement • June 4th, 2020 • Orasure Technologies Inc • Surgical & medical instruments & apparatus • New York

OraSure Technologies, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 8,000,000 shares of common stock, par value $0.000001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,200,000 shares of common stock, par value $0.000001 per share, of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock, par value $0.000001 per share, of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

ISSUER AND TRUSTEE INDENTURE
Indenture • July 3rd, 2003 • Orasure Technologies Inc • Surgical & medical instruments & apparatus • New York
RECITALS
Loan and Security Agreement • November 13th, 2002 • Orasure Technologies Inc • Surgical & medical instruments & apparatus • Pennsylvania
EXHIBIT 4.2 RIGHTS AGREEMENT
Rights Agreement • August 8th, 2000 • Orasure Technologies Inc • Surgical & medical instruments & apparatus • Delaware
OraSure Technologies, Inc. 6,100,000 Shares Common Stock ($0.000001 par value) Underwriting Agreement
Underwriting Agreement • July 11th, 2012 • Orasure Technologies Inc • Surgical & medical instruments & apparatus • New York

OraSure Technologies, Inc., a corporation organized under the laws of the State of Delaware (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, the number of shares of common stock, $0.000001 par value (“Common Stock”), of the Company set forth in Schedule I hereto (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to the number of additional shares of Common Stock set forth in Schedule II hereto (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). The term Representatives as used herein shall mean you, as Underwriters, and the terms Representatives and Underwriters shall mean either the singular or plural as the context requires. Any reference h

AGREEMENT ---------
Production Agreement • March 29th, 2002 • Orasure Technologies Inc • Surgical & medical instruments & apparatus
BETWEEN
Commercial Lease • August 8th, 2000 • Orasure Technologies Inc • Surgical & medical instruments & apparatus • Pennsylvania
EMPLOYMENT AGREEMENT
Employment Agreement • October 5th, 2006 • Orasure Technologies Inc • Surgical & medical instruments & apparatus • Delaware

This Employment Agreement is entered into as of October 2, 2006 (this “Agreement”), between Mark L. Kuna (“Employee”) and OraSure Technologies, Inc., a Delaware corporation (the “Company”).

BACKGROUND
Supply Agreement • November 13th, 2002 • Orasure Technologies Inc • Surgical & medical instruments & apparatus • North Carolina
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT
Employment Agreement • December 19th, 2008 • Orasure Technologies Inc • Surgical & medical instruments & apparatus • Pennsylvania

This Amendment No. 1 to Employment Agreement entered into as of December 16, 2008 (this “Amendment”), between Douglas A. Michels (“Employee”) and OraSure Technologies, Inc., a Delaware corporation (the “Company”).

EMPLOYMENT AGREEMENT
Employment Agreement • March 1st, 2022 • Orasure Technologies Inc • Surgical & medical instruments & apparatus • Pennsylvania

This Employment Agreement (this “Agreement”) is entered into as of November 29, 2021 (the “Effective Date”), between Agnieszka M. Gallagher (“Employee”) and OraSure Technologies, Inc. (“OraSure” or the “Company”).

AutoNDA by SimpleDocs
ORASURE TECHNOLOGIES, INC. UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Asset Purchase Agreement • August 19th, 2019 • Orasure Technologies Inc • Surgical & medical instruments & apparatus

On August 15, 2019, OraSure Technologies, Inc. (the “Company”) entered into an asset purchase agreement (the “Agreement”) between the Company and CryoConcepts, LP (“CryoConcepts”), pursuant to which the Company has agreed to sell certain assets associated with the Company’s cryosurgical systems business (the “Business”), including the Company’s professional Histofreezer product line and several private label cryosurgical products sold in the consumer market, along with related patents and trademarks, customer contracts and goodwill associated with the Business, for an aggregate purchase price of $12.0 million in cash (the “Sale”).

RETIREMENT AGREEMENT
Retirement Agreement • May 5th, 2020 • Orasure Technologies Inc • Surgical & medical instruments & apparatus • Pennsylvania

This Retirement Agreement (“Agreement”) is made as of May 1, 2020, by and between Anthony Zezzo II (“Executive”) and OraSure Technologies, Inc. (collectively, with its predecessors, successors, affiliates and subsidiaries, the “Company”) (jointly referred to as the “Parties” and singularly as a “Party”):

BETWEEN
Commercial Lease • March 29th, 2002 • Orasure Technologies Inc • Surgical & medical instruments & apparatus • Pennsylvania
CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. SUCH OMISSIONS DENOTED WITH [***].
Master Program Services and Product Co-Promotion Agreement • December 5th, 2014 • Orasure Technologies Inc • Surgical & medical instruments & apparatus • Delaware

This Master Program Services and Product Co-Promotion Agreement (this “Agreement”) is made and entered into effective as of June 10, 2014 (the “Effective Date”) by and between ORASURE TECHNOLOGIES, INC., a Delaware corporation having a principal place of business at 220 East First Street, Bethlehem, Pennsylvania 18015 (“OraSure”), and ABBVIE BAHAMAS LTD. a Bahamian limited corporation having a principal place of business at Sassoon House, Shirley Street & Victoria Avenue, PO Box SS-5383, Nassau, New Providence, Bahamas (“AbbVie”). OraSure and AbbVie are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”

SETTLEMENT AGREEMENT
Settlement Agreement • March 15th, 2010 • Orasure Technologies Inc • Surgical & medical instruments & apparatus • Delaware

THIS SETTLEMENT AGREEMENT (this “Agreement”) effective as of November 17, 2009 (the “Effective Date”), is entered into by and among INVERNESS MEDICAL INNOVATIONS, INC., a Delaware corporation (“IMI”), with a place of business at 51 Sawyer Road, Suite 200, Waltham, Massachusetts 02453, USA, INVERNESS MEDICAL SWITZERLAND GmbH, a Swiss private company (“IMS”), with a place of business at Bahnhofstrasse 28, CH-6300 Zug, Switzerland (IMI and IMS, together, “Inverness”), and ORASURE TECHNOLOGIES, INC., a Delaware corporation (“OraSure”), with a place of business at 220 East First Street, Bethlehem, Pennsylvania 18015, USA.

TENTH AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan and Security Agreement • May 25th, 2012 • Orasure Technologies Inc • Surgical & medical instruments & apparatus

This Tenth Amendment to Loan and Security Agreement is entered into as of May 23, 2012 (the “Amendment”), by and between COMERICA BANK (“Bank”) and ORASURE TECHNOLOGIES, INC. (“Borrower”).

RESTRICTED SHARE GRANT AGREEMENT (Executive Officers)
Restricted Share Grant Agreement • March 14th, 2012 • Orasure Technologies Inc • Surgical & medical instruments & apparatus • Pennsylvania

This Restricted Share Grant Agreement (“Agreement”) is entered into as of [DATE] between ORASURE TECHNOLOGIES, INC., a Delaware corporation (“OraSure” or the “Company”), and [NAME] (“Participant”).

RESTRICTED SHARE GRANT AGREEMENT (Non-Employee Directors)
Restricted Share Grant Agreement • March 14th, 2012 • Orasure Technologies Inc • Surgical & medical instruments & apparatus • Pennsylvania

This Restricted Share Grant Agreement (“Agreement”) is entered into as of [DATE] between ORASURE TECHNOLOGIES, INC., a Delaware corporation (“OraSure” or the “Company”), and [NAME] (“Participant”).

AMENDMENT NO. 3 TO EMPLOYMENT AGREEMENT
Employment Agreement • March 31st, 2015 • Orasure Technologies Inc • Surgical & medical instruments & apparatus • Pennsylvania

This Amendment No. 3 to Employment Agreement entered into as of March 27, 2015 (this “Amendment”), between Jack E. Jerrett (“Employee”) and OraSure Technologies, Inc., a Delaware corporation (the “Company”).

DISTRIBUTION AGREEMENT
Distribution Agreement • August 4th, 2004 • Orasure Technologies Inc • Surgical & medical instruments & apparatus • Pennsylvania

THIS DISTRIBUTION AGREEMENT (this “Agreement”) is made and entered into this 24th day of April 2003, by and between Medtech Holdings, Inc., a Delaware corporation with principal offices at 90 North Broadway, Irvington, New York 10533 (“Distributor”), and OraSure Technologies, Inc., a Delaware corporation with principal offices at 220 East First Street, Bethlehem, Pennsylvania 18015-1360 (“OSUR”).

EIGHTH AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan and Security Agreement • November 23rd, 2011 • Orasure Technologies Inc • Surgical & medical instruments & apparatus

This Eighth Amendment to Loan and Security Agreement is entered into as of November 18, 2011 (the “Amendment”), by and between COMERICA BANK (“Bank”) and ORASURE TECHNOLOGIES, INC. (“Borrower”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!